Baghdad Declaration sets new regional agenda for type 2 diabetes prevention in MENA

Published: 18 Nov 2026

The International Diabetes Federation (IDF) Middle East and North Africa (MENA) region marked a milestone in regional diabetes prevention with the presentation and ceremonial signing of the Baghdad Declaration for the Prevention of Type 2 Diabetes on 7 November, during a joint gathering in Baghdad, Iraq. The gathering brought together the 5th Levant Endocrinology & Diabetes Congress, the IDF-MENA Regional Meeting, and the Iraqi Diabetes & Endocrinology Association International Conference.

According to IDF estimates released in 2025, the MENA region has the highest diabetes prevalence worldwide, at 17.6%. The number of people living with diabetes is projected to increase by 92%, reaching 163 million by 2050. The region also has the highest proportion of diabetes-related deaths among people under 60 (21.6%). Despite accounting for 14.4% of people living with diabetes globally, MENA represents just 3.4% of global diabetes-related health expenditure.

Building action from evidence

Developed as a collaborative regional framework, the Baghdad Declaration outlines 46 recommendations across 15 domains, organised into nine practical themes to guide type 2 diabetes prevention across the MENA region.

The nine themes cover:

  • Risk identification and early detection
  • Strengthening prevention through primary healthcare
  • Follow-up for people with prediabetes
  • Structured lifestyle interventions
  • Obesity and cardiometabolic risk management
  • Targeted pharmacological prevention
  • Community-based approaches
  • Health policy and equity
  • Monitoring and evaluation

The Declaration recognises the need to adapt evidence-based prevention strategies to specific health systems, resources, and priorities of countries across the region.

A joint commitment to implementation

The formal presentation featured opening remarks by Dr Samih Abed Odhaib, followed by Dr Nadima Shegem, who outlined the scientific rationale underpinning the Declaration. Dr Odhaib subsequently presented its recommendations, while IDF MENA Regional Chair Dr Mohamed Eltom introduced the finalised implementation framework.

The Declaration includes an implementation framework to help countries put the recommendations into practice. It proposes setting up teams responsible for implementation, followed by an initial 100-day period to establish activities and assess progress. Countries are also encouraged to introduce pilot initiatives with clear targets and regularly evaluate their results to identify approaches that could be adopted more widely.

The framework considers differences in healthcare resources and capacity across the region, giving countries autonomy to adapt the recommendations to their national needs and priorities.

Strengthening regional collaboration

The Declaration was formally presented at a signing ceremony attended by members of the Declaration Steering Committee, IDF leadership, Iraqi representatives and congress presidents.

The initiative follows discussions at the IDF-MENA Regional Council Meeting and the congress’s National Diabetes Programme workshop, where participants considered national priorities, targets, and approaches to implementing diabetes prevention programmes.

The Baghdad Declaration provides a common framework for countries across MENA to strengthen type 2 diabetes prevention. The next step is to implement its recommendations, monitor progress, and share experiences between countries to improve prevention efforts across the region.

 

Keep up to date with all the work we’re doing